XML 47 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Nov. 24, 2013
Nov. 25, 2012
Consolidated net income $ 8,304,000 $ 13,435,000
Depreciation and amortization 3,787,000 3,661,000
Stock-based compensation expense 639,000 671,000
Tax benefit from stock-based compensation expense (175,000) (1,814,000)
Loss on disposal of property and equipment 124,000 180,000
Deferred taxes 4,050,000 3,039,000
Contingent Consideration   (3,933,000)
Change in investment in non-public company (fair market value) (7,700,000) (5,252,000)
Accounts receivable, net (5,673,000) (8,644,000)
Accounts receivable, related party 540,000 10,000
Income taxes receivable 262,000 1,840,000
Inventories, net (2,752,000) (2,391,000)
Prepaid expenses and other current assets (1,361,000) (436,000)
Accounts payable 3,049,000 3,300,000
Related party accounts payable (544,000) (351,000)
Accrued compensation (743,000) (1,223,000)
Other accrued liabilities 2,452,000 (616,000)
Deferred revenue 34,000 908,000
Net cash provided by operating activities 4,293,000 2,384,000
Purchases of property and equipment (7,681,000) (3,280,000)
Purchase of marketable securities (1,417,000) (2,459,000)
Net cash used in investing activities (6,136,000) (5,239,000)
Proceeds from sale of common stock 1,253,000 651,000
Taxes paid by Company for stock swaps and RSUs (1,219,000) (49,000)
Tax benefit from stock-based compensation expense 175,000 1,814,000
Earn out payment from Lifecore acquisition   (9,650,000)
Payments on long-term debt (3,128,000) (3,090,000)
Payments on lines of credit (3,000,000) (4,166,000)
Decrease in other assets 36,000 345,000
Payments to minority interest holders (226,000) (321,000)
Net cash used in financing activities (6,109,000) (14,466,000)
Net decrease in cash and cash equivalents (7,952,000) (17,321,000)
Cash and cash equivalents at beginning of period 13,718,000 [1] 22,177,000
Cash and cash equivalents at end of period 5,766,000 4,856,000
Earnout [Member]
   
Contingent Consideration   (3,933,000)
Change In Value [Member]
   
Contingent Consideration   3,933,000
Marketable Maturities [Member]
   
Proceeds from maturities of marketable securities $ 2,962,000 $ 500,000
[1] Derived from audited financial statements.